1. Home
  2. IAF vs NAUT Comparison

IAF vs NAUT Comparison

Compare IAF & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IAF
  • NAUT
  • Stock Information
  • Founded
  • IAF 1985
  • NAUT 2016
  • Country
  • IAF United States
  • NAUT United States
  • Employees
  • IAF N/A
  • NAUT N/A
  • Industry
  • IAF Finance/Investors Services
  • NAUT Biotechnology: Laboratory Analytical Instruments
  • Sector
  • IAF Finance
  • NAUT Industrials
  • Exchange
  • IAF Nasdaq
  • NAUT Nasdaq
  • Market Cap
  • IAF 103.9M
  • NAUT 91.5M
  • IPO Year
  • IAF N/A
  • NAUT N/A
  • Fundamental
  • Price
  • IAF $4.44
  • NAUT $0.79
  • Analyst Decision
  • IAF
  • NAUT Hold
  • Analyst Count
  • IAF 0
  • NAUT 2
  • Target Price
  • IAF N/A
  • NAUT $3.88
  • AVG Volume (30 Days)
  • IAF 90.4K
  • NAUT 261.7K
  • Earning Date
  • IAF 01-01-0001
  • NAUT 07-29-2025
  • Dividend Yield
  • IAF 11.44%
  • NAUT N/A
  • EPS Growth
  • IAF N/A
  • NAUT N/A
  • EPS
  • IAF N/A
  • NAUT N/A
  • Revenue
  • IAF N/A
  • NAUT N/A
  • Revenue This Year
  • IAF N/A
  • NAUT N/A
  • Revenue Next Year
  • IAF N/A
  • NAUT N/A
  • P/E Ratio
  • IAF N/A
  • NAUT N/A
  • Revenue Growth
  • IAF N/A
  • NAUT N/A
  • 52 Week Low
  • IAF $3.60
  • NAUT $0.66
  • 52 Week High
  • IAF $4.59
  • NAUT $3.09
  • Technical
  • Relative Strength Index (RSI)
  • IAF 56.50
  • NAUT 56.49
  • Support Level
  • IAF $4.35
  • NAUT $0.69
  • Resistance Level
  • IAF $4.48
  • NAUT $0.75
  • Average True Range (ATR)
  • IAF 0.06
  • NAUT 0.05
  • MACD
  • IAF -0.01
  • NAUT 0.00
  • Stochastic Oscillator
  • IAF 50.00
  • NAUT 83.20

About IAF abrdn Australia Equity Fund Inc.

Aberdeen Australia Equity Fund Inc is a non-diversified closed-end investment management company. With a core focus on long-term capital appreciation, it invests predominantly in equity securities listed on the Australian Stock Exchange. Its secondary objective is current income, which it expects to derive from dividends and interest on Australian corporate and governmental securities. Its investment portfolio comprises diversified sectors that include Financials, Health Care, Materials, Information Technology, Real Estate, and other sectors.

About NAUT Nautilus Biotechnolgy Inc.

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.

Share on Social Networks: